Holmberg K, Björk E, Bake B, Edman P
Department of Otorhinolaryngology, Lundby GLF Hospitals, University of Göteborg, Sweden.
Rhinology. 1994 Jun;32(2):74-7.
The effect of the nasal administration of degradable starch microspheres (DSM) on the mucociliary system and the geometry of the nasal cavities were evaluated in 15 healthy volunteers. The baseline values for mucociliary clearance of the right nasal cavity were determined on two separate days for each subject using the saccharin-dyes test. Acoustic rhinometry was performed before and during the saccharin-dyes test. The patients then started the treatment period and inhaled 10 mg of DSM intranasally once daily in each nostril for 8 days. The saccharin-dyes test was performed 5 min after the deposition of the DSM on day 1 and day 8. The geometry of the nasal cavities was determined before, 7 min after deposition, and after the end of the saccharin test. Both tests were also performed two days after the end of the treatment period. Each subject was examined by means of rhinoscopy on every visit during the investigation. No changes in mucociliary clearance or in the geometry of the nasal cavities were found after repeated administration of starch microspheres. Thus, intranasally-administered degradable starch microspheres did not have an adverse effect on human nasal mucociliary clearance, and the DSM did not cause any congestion or decongestion of the mucosa.
在15名健康志愿者中评估了经鼻给药可降解淀粉微球(DSM)对鼻黏膜纤毛系统和鼻腔几何形态的影响。使用糖精-染料试验在两个不同日期为每个受试者测定右侧鼻腔黏膜纤毛清除的基线值。在糖精-染料试验之前和试验期间进行鼻声反射测量。然后患者开始治疗期,每个鼻孔每天经鼻吸入10mg DSM,持续8天。在第1天和第8天,在DSM沉积后5分钟进行糖精-染料试验。在沉积前、沉积后7分钟以及糖精试验结束后测定鼻腔的几何形态。在治疗期结束后两天也进行了这两项试验。在调查期间的每次就诊时,通过鼻镜检查对每个受试者进行检查。重复给予淀粉微球后,未发现黏膜纤毛清除或鼻腔几何形态有变化。因此,经鼻给药的可降解淀粉微球对人体鼻黏膜纤毛清除没有不良影响,并且DSM不会引起黏膜的任何充血或减轻充血。